Alirocumab: Focus on high CV risk patients and mortality outcomes in Odyssey
0 SAR
Checkout
Overview
Insights from the clinical program of Odessey showing the positive results of CV outcomes on very high risk patients category with significant reduction for the first time in all cause death .This Class for
- Clinical Pharmacy
- Pharmacy
- Physician
- Resident / Fellow
Related Classes
- Staying on track: Optimizing the lipid-lowering pathway whilst avoiding treatment gaps
- How to prevent the Event in People with T2D and ASCVD